That's what we do at Elevate - we offer more than funding. With experienced personnel, tested tools, and structured assistance and investment programs, we get entrepreneurs where they need to go. In the end, we all succeed.
The goal of the 21st Century Fund is to support the resolution of next-stage capital formation issues by co-investing with institutional investors in order to further build innovative, high-impact, high-growth companies.
As the 21 Fund's manager, Elevate works with early revenue generating companies to solve product demonstration and market penetration issues in order to accelerate company growth, milestone achievement, and job creation.
Technical and business analysis is conducted by Elevate Ventures staff using a structured internal venture validation process. If necessary, Elevate Ventures' Entrepreneurs-in-Residence work with applicants to ensure that the technical and business plans are structured to make this review efficient and to provide useful feedback to the company.
The 21st Century Fund is sensitive to the acute challenges facing early-stage life science companies, especially in therapeutic verticals. We will continue to be open to such opportunities and will strive to meet associated capital-intensive product development needs alongside institutional or strategic investors.
The 21 Fund's maximum investment size is $2 million per company.
All investments are initially made in convertible debt with finalization in convertible debt or equity instruments with the following contingencies:
Establishment and maintenance of proper corporate governance procedures
Appointment of a 21 Fund-designated person to the company's governing Board of Directors
Financial and operational reporting
Private co-investment from institutional investors. We may consider co-investment from angel investors if such investors can demonstrate pre-existing connection with the venture capital community and are likely to help entice institutional investment in the future
